Teclistamab‐Induced Remission of Chronic Immune Thrombocytopenia in a Patient With Multiple Myeloma
ABSTRACT We report the case of a 76‐year‐old woman with refractory immune thrombocytopenia (ITP) and multiple myeloma (MM) who achieved remission of both conditions following teclistamab treatment. After failing multiple ITP therapies, her platelet count continued to decline. Initiation of teclistam...
Saved in:
| Main Authors: | Renata Quevedo‐Salazar, José Miguel Yáñez‐Reyes, Elías Eugenio González‐López, Ana Varela‐Constantino, Andrés Gómez‐De León, Xitlaly Judith González‐Leal, David Gómez‐Almaguer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | eJHaem |
| Online Access: | https://doi.org/10.1002/jha2.70062 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case Report: Teclistamab in the treatment of idiopathic immune thrombocytopenia in patients with multiple myeloma
by: Asis Shrestha, et al.
Published: (2025-04-01) -
Injection site reaction to teclistamab in a patient with multiple myeloma
by: Isabel C. Yoon, BS, et al.
Published: (2025-02-01) -
Teclistamab for patients with heavily pretreated relapsed/refractory multiple myeloma and renal impairment
by: Danai Dima, et al.
Published: (2025-07-01) -
Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma
by: James A. Davis, et al.
Published: (2025-03-01) -
Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamab
by: Charles Pei, et al.
Published: (2025-08-01)